Literature DB >> 23806583

Catatonia in DSM-5.

Rajiv Tandon1, Stephan Heckers, Juan Bustillo, Deanna M Barch, Wolfgang Gaebel, Raquel E Gur, Dolores Malaspina, Michael J Owen, Susan Schultz, Ming Tsuang, Jim van Os, William Carpenter.   

Abstract

Although catatonia has historically been associated with schizophrenia and is listed as a subtype of the disorder, it can occur in patients with a primary mood disorder and in association with neurological diseases and other general medical conditions. Consequently, catatonia secondary to a general medical condition was included as a new condition and catatonia was added as an episode specifier of major mood disorders in DSM-IV. Different sets of criteria are utilized to diagnose catatonia in schizophrenia and primary mood disorders versus neurological/medical conditions in DSM-IV, however, and catatonia is a codable subtype of schizophrenia but a specifier for major mood disorders without coding. In part because of this discrepant treatment across the DSM-IV manual, catatonia is frequently not recognized by clinicians. Additionally, catatonia is known to occur in several conditions other than schizophrenia, major mood disorders, or secondary to a general medical condition. Four changes are therefore made in the treatment of catatonia in DSM-5. A single set of criteria will be utilized to diagnose catatonia across the diagnostic manual and catatonia will be a specifier for both schizophrenia and major mood disorders. Additionally, catatonia will also be a specifier for other psychotic disorders, including schizoaffective disorder, schizophreniform disorder, brief psychotic disorder, and substance-induced psychotic disorder. A new residual category of catatonia not otherwise specified will be added to allow for the rapid diagnosis and specific treatment of catatonia in severely ill patients for whom the underlying diagnosis is not immediately available. These changes should improve the consistent recognition of catatonia across the range of psychiatric disorders and facilitate its specific treatment. Published by Elsevier B.V.

Entities:  

Keywords:  Catatonia; Classification; DSM; DSM-5; Diagnosis; Mood disorder; Nosology; Schizophrenia

Mesh:

Year:  2013        PMID: 23806583     DOI: 10.1016/j.schres.2013.04.034

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  44 in total

1.  Regression: Diagnosis, Evaluation, and Management.

Authors:  Hermioni N Lokko; Theodore A Stern
Journal:  Prim Care Companion CNS Disord       Date:  2015-05-14

2.  Going Back to Kahlbaum's Psychomotor (and GABAergic) Origins: Is Catatonia More Than Just a Motor and Dopaminergic Syndrome?

Authors:  Dusan Hirjak; Katharina M Kubera; R Christian Wolf; Georg Northoff
Journal:  Schizophr Bull       Date:  2020-02-26       Impact factor: 9.306

3.  Catatonia due to alprazolam withdrawal.

Authors:  Siddharth Iyengar; Charles Bornmann; Farid Abdelmalak; Tulisa LaRocca
Journal:  BMJ Case Rep       Date:  2018-12-14

4.  Impact of DSM-5 changes on the diagnosis and acute treatment of schizophrenia.

Authors:  Taina Mattila; Maarten Koeter; Tamar Wohlfarth; Jitschak Storosum; Wim van den Brink; Lieuwe de Haan; Eske Derks; Hubertus Leufkens; Damiaan Denys
Journal:  Schizophr Bull       Date:  2014-12-20       Impact factor: 9.306

Review 5.  Prevalence of Catatonia and Its Moderators in Clinical Samples: Results from a Meta-analysis and Meta-regression Analysis.

Authors:  Marco Solmi; G Giorgio Pigato; Beatrice Roiter; Argentina Guaglianone; Luca Martini; Michele Fornaro; Francesco Monaco; Andrè F Carvalho; Brendon Stubbs; Nicola Veronese; Christoph U Correll
Journal:  Schizophr Bull       Date:  2018-08-20       Impact factor: 9.306

Review 6.  Neuroleptic malignant syndrome or catatonia? Trying to solve the catatonic dilemma.

Authors:  Fabian U Lang; Silke Lang; Thomas Becker; Markus Jäger
Journal:  Psychopharmacology (Berl)       Date:  2014-11-20       Impact factor: 4.530

Review 7.  Motor Abnormalities: From Neurodevelopmental to Neurodegenerative Through "Functional" (Neuro)Psychiatric Disorders.

Authors:  Victor Peralta; Manuel J Cuesta
Journal:  Schizophr Bull       Date:  2017-09-01       Impact factor: 9.306

8.  Close Reading of Old Texts-Towards a Psychiatric Hermeneutics.

Authors:  Stephan Heckers
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

9.  GABA and Negative Affect-Catatonia as Model of RDoC-Based Investigation in Psychiatry.

Authors:  Dusan Hirjak; Robert Christian Wolf; Georg Northoff
Journal:  Schizophr Bull       Date:  2019-10-24       Impact factor: 9.306

10.  Microglia ablation alleviates myelin-associated catatonic signs in mice.

Authors:  Hana Janova; Sahab Arinrad; Evan Balmuth; Marina Mitjans; Johannes Hertel; Mohamad Habes; Robert A Bittner; Hong Pan; Sandra Goebbels; Martin Begemann; Ulrike C Gerwig; Sönke Langner; Hauke B Werner; Sarah Kittel-Schneider; Georg Homuth; Christos Davatzikos; Henry Völzke; Brian L West; Andreas Reif; Hans Jörgen Grabe; Susann Boretius; Hannelore Ehrenreich; Klaus-Armin Nave
Journal:  J Clin Invest       Date:  2017-12-18       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.